Scynexis Inc (SCYX):企業の財務・戦略的SWOT分析

◆英語タイトル:Scynexis Inc (SCYX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH122661FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥81,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥121,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Scynexis Inc (Scynexis) is a pharmaceutical company that discovers, develops and commercializes novel anti-infective for various therapeutic needs. The company offers pipeline products such as SCY-078, is used for invasive fungal infections; SCY-635, is used for the treatment of Hepatitis C (HCV); SCYX-7158, is used for sleeping sickness; SCY-641, is for human health, among others. Its SCY-078 is a chemical class of glucan synthase inhibitors that blocks target in infectious fungi by interfering with the assembly of the fungal cell wall and prevents the growth of fungal species. Scynexis provides its drug pipeline solutions to pharmaceutical, healthcare and life sciences companies, among others. The company develops products by using technology platforms such as enfumafungin platform, cyclophilin platform and calcineurin platform, among others. Scynexis is headquartered in Jersey City, New Jersey, the US.

Scynexis Inc Key Recent Developments

Mar 29,2021: SCYNEXIS Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
Feb 17,2021: SCYNEXIS Announces Licensing Agreement and Strategic Partnership with Hansoh Pharma for Rights to Ibrexafungerp in Greater China
Feb 17,2021: SCYNEXIS and Hansoh Pharma Announce Licensing Agreement and Strategic Partnership for Ibrexafungerp in Greater China

This comprehensive SWOT profile of Scynexis Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Scynexis Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Scynexis Inc – Key Information
Scynexis Inc – Overview
Scynexis Inc – Key Employees
Scynexis Inc – Key Employee Biographies
Scynexis Inc – Key Operational Heads
Scynexis Inc – Major Products and Services
Scynexis Inc – History
Scynexis Inc – Company Statement
Scynexis Inc – Locations And Subsidiaries
Scynexis Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Scynexis Inc – Business Description
Scynexis Inc – Corporate Strategy
Scynexis Inc – SWOT Analysis
SWOT Analysis – Overview
Scynexis Inc – Strengths
Scynexis Inc – Weaknesses
Scynexis Inc – Opportunities
Scynexis Inc – Threats
Scynexis Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Scynexis Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Scynexis Inc, Key Information
Scynexis Inc, Key Ratios
Scynexis Inc, Share Data
Scynexis Inc, Major Products and Services
Scynexis Inc, History
Scynexis Inc, Key Employees
Scynexis Inc, Key Employee Biographies
Scynexis Inc, Key Operational Heads
Scynexis Inc, Other Locations
Scynexis Inc, Subsidiaries
Scynexis Inc, Key Competitors
Scynexis Inc, SWOT Analysis
Scynexis Inc, Ratios based on current share price
Scynexis Inc, Annual Ratios
Scynexis Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Scynexis Inc (SCYX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pure Technologies Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Pure Technologies Ltd. (Pure Technologies) develops technologies for inspection, monitoring and management of physical infrastructure such as buildings, water and hydrocarbon pipelines, and bridges. It provides proprietary monitoring equipment for pipelines, bridges and structures; technical …
  • Kadimastem Ltd (KDST):企業の財務・戦略的SWOT分析
    Summary Kadimastem Ltd (Kadimastem) is a clinical stage biopharmaceutical company that develops industrial regenerative medicines to treat neuro-degenerative diseases. Its technology platform enables the manufacturing of islet-like endocrine cells (differentiated cells) and glia restricted progenito …
  • Tata Steel Europe Ltd:企業の戦略・SWOT・財務情報
    Tata Steel Europe Ltd - Strategy, SWOT and Corporate Finance Report Summary Tata Steel Europe Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • International Montoro Resources Inc (IMT):企業の財務・戦略的SWOT分析
    Summary International Montoro Resources Inc (International Montoro) is a mining and mineral exploration company. The company provides acquisition, exploration, and development of nickel, copper, cobalt, gold, rare earth elements and uranium mineral prospects, among others. It offers property such as …
  • Diffusion Pharmaceuticals Inc (DFFN):企業の財務・戦略的SWOT分析
    Summary Diffusion Pharmaceuticals Inc (Diffusion), formerly Diffusion Pharmaceuticals LLC is a clinical stage biotechnology company that develops standard of care therapies. The company improves cancer treatments such as radiation therapy and chemotherapy in treatment-resistant solid tumors, includi …
  • Horizon Discovery Group Plc (HZD):医療機器:M&Aディール及び事業提携情報
    Summary Horizon Discovery Group Plc (Horizon Discovery) is a life science company that discovers and develops genetically-modified cell lines using a proprietary translational genomics platform. The company offers products such as cell lines, reference standards and in vivo models. It also offers se …
  • The Western Union Company:企業のM&A・事業提携・投資動向
    The Western Union Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Western Union Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Theranyx Sarl:製薬・医療:M&Aディール及び事業提携情報
    Summary Theranyx Sarl is a bio technology company that develops novel therapeutic drugs and solutions to treat cancer. The company’s main line business involved in generation of functional antibodies to target GPCRs and ion channel receptors. Its antibodies named as Therabodies has scope in target v …
  • Bruce Power L.P.:企業の戦略的SWOT分析
    Bruce Power L.P. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Benesse Holdings Inc (9783):企業の財務・戦略的SWOT分析
    Benesse Holdings Inc (9783) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Heerema International Group Services SA:企業の戦略的SWOT分析
    Heerema International Group Services SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Quantum Corp (QTM):企業の財務・戦略的SWOT分析
    Summary Quantum Corp (Quantum) is a technology company that offers intelligent solutions for capturing, sharing and preserving digital assets over the data lifecycle. The company provides products such as stornext scale-out storage, stornext pro solutions, lattus extended online, Q-cloud archive, qu …
  • Proactis Holdings Plc (PHD):企業の財務・戦略的SWOT分析
    Summary Proactis Holdings PLC (Proactis) is a technology company. The company develops and provides spend control and eprocurement solutions. It offers various solutions such as purchase-to-pay, eCommerce, source-to-contract, and global framework. It provides source-to-contract solutions for supplie …
  • LeMaitre Vascular Inc (LMAT):製品パイプライン分析
    Summary LeMaitre Vascular Inc (LeMaitre Vascular) is a medical device company. It undertakes the development, manufacture, marketing and sale of devices that are used in the treatment of peripheral vascular diseases. The company offers several product lines for vascular surgery and endovascular proc …
  • Aer Lingus Ltd:企業の戦略・SWOT・財務情報
    Aer Lingus Ltd - Strategy, SWOT and Corporate Finance Report Summary Aer Lingus Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Living Cell Technologies Ltd (LCT):製薬・医療:M&Aディール及び事業提携情報
    Summary Living Cell Technologies Ltd (LCT) is a biotechnology company that develops cell-based therapeutics for the treatment of neurological diseases, diabetes, and stroke and hearing loss. It focuses on discovering regenerative treatments which restore function using naturally occurring cells. LCT …
  • Svenska Cellulosa AB:戦略・SWOT・企業財務分析
    Svenska Cellulosa AB - Strategy, SWOT and Corporate Finance Report Summary Svenska Cellulosa AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • InsuLine Medical Ltd (INSL)-医療機器分野:企業M&A・提携分析
    Summary InsuLine Medical Ltd (InsuLine Medical) is a medical device company that develops, manufactures and markets device which enables patients on intensive insulin therapy. The company’s products include InsuPad and InsuPatch. Its InsuPad is a patch for syringes and insulin pens; and InsuPatch is …
  • Murata Manufacturing Co., Ltd.:企業の戦略・SWOT・財務分析
    Murata Manufacturing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Murata Manufacturing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Universal Music Group Inc:企業の戦略的SWOT分析
    Universal Music Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆